Biomea Fusion, Inc. (BMEA) vs Cognition Therapeutics, Inc. (CGTX)
A side-by-side comparison of Biomea Fusion, Inc. and Cognition Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.29HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
CGTX
Cognition Therapeutics, Inc.
$0.95HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — BMEA vs CGTX
growth of $100 · dividends reinvested · last 5yBMEA -89.5% (-36.3%/yr)CGTX -92.7% (-40.7%/yr)BMEA compounded faster over this window
BMEA CGTX
BMEA vs CGTX: by the numbers
- •BMEA is the larger company ($93M vs $85M market cap).
Metrics side by side
Valuation
| Metric | BMEA | CGTX |
|---|---|---|
| P/B ratio | 7.66 | 2.57 |
Profitability
| Metric | BMEA | CGTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -268.09% | -50.80% |
| ROIC | -220.02% | -109.43% |
Growth (annualized)
| Metric | BMEA | CGTX |
|---|---|---|
| Total return CAGR (5Y) | -36.56% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.